{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-219539","form_type":"8-K","ticker":"TEVA","cik":"0000818686","company_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","filed_at":"2023-08-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.723441+00:00","generated_at":"2026-06-11T04:30:32.270086+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"litigation","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Teva settles DOJ price-fixing charges with $225M fine, DPA; avoids federal exclusion","bullets":["Teva enters Deferred Prosecution Agreement with DOJ over 2020 price-fixing charges for generic drugs.","Fine of $225M payable over 5 years: $22.5M/yr 2024-2027, $135M in 2028.","Teva to donate $50M of two generic products (at wholesale cost) and divest one generic product.","Admits a single former employee engaged in three instances of collusion with competitors (2013-2015).","DPA term is 3 years; upon compliance and payment, charges dismissed with prejudice."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-219539","json":"https://secwatch.observer/filing/0001193125-23-219539.json","markdown":"https://secwatch.observer/filing/0001193125-23-219539.md","text":"https://secwatch.observer/filing/0001193125-23-219539.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/818686/000119312523219539/0001193125-23-219539-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/818686/000119312523219539/d479429d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T04:30:32.270086+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}